Attention Doctors and Chemists:
Achieving acid control round the clock is always challenging whenever you take / prescribe any acid reducing agents. Reason being the effect of conventional PPIs tend to diminish during a 24 hour period due to variable mean plasma concentration - resulting in breakthrough of symptoms.
To address the unmet need of patient’s with Acid Peptic Disease - in providing 24 hour acid control - Ferozsons is proudly launching another innovative product using phenomenal technology of DDR (Dual Delayed Release ) with the name of DEXIVA (Dexlansoprazole). Due to DDR technology Dexiva provides 2 releases of medicine in one pill. With this dual release, Dexiva is detectable throughout 24 hour post dose - resulting in acid control - All Day, All Night.
Dexlansoprazole is the only FDA approved PPI with Dual Delayed Releases for 24 hour acid control in patient with Acid Peptic Disease.
*Please Note:This information is intended for Doctors and Healthcare professionals only.
#GERD #Dexiva #acidcontrol #PeopleTrustUs #PuttingPatientsFirst #BecauseWeCare